237 related articles for article (PubMed ID: 27718047)
1. Generation and evaluation of a genetically attenuated Newcastle disease virus rGM-VIIm as a genotype-matched vaccine.
Sun M; Xiang B; Li Y; Xie P; Gao S; Kang Y; Gao P; Li Y; Wang Z; Liang J; Yu D; Ren T
Virus Genes; 2017 Feb; 53(1):35-43. PubMed ID: 27718047
[TBL] [Abstract][Full Text] [Related]
2. Generation by reverse genetics of an effective, stable, live-attenuated newcastle disease virus vaccine based on a currently circulating, highly virulent Indonesian strain.
Xiao S; Nayak B; Samuel A; Paldurai A; Kanabagattebasavarajappa M; Prajitno TY; Bharoto EE; Collins PL; Samal SK
PLoS One; 2012; 7(12):e52751. PubMed ID: 23285174
[TBL] [Abstract][Full Text] [Related]
3. A novel genotype VII Newcastle disease virus vaccine candidate generated by mutation in the L and F genes confers improved protection in chickens.
Ji Y; Liu T; Du Y; Cui X; Yu Q; Wang Z; Zhang J; Li Y; Zhu Q
Vet Microbiol; 2018 Mar; 216():99-106. PubMed ID: 29519533
[TBL] [Abstract][Full Text] [Related]
4. A vaccine candidate of attenuated genotype VII Newcastle disease virus generated by reverse genetics.
Hu S; Ma H; Wu Y; Liu W; Wang X; Liu Y; Liu X
Vaccine; 2009 Feb; 27(6):904-10. PubMed ID: 19095026
[TBL] [Abstract][Full Text] [Related]
5. Generation of a genotype VII Newcastle disease virus vaccine candidate with high yield in embryonated chicken eggs.
Hu Z; Hu S; Meng C; Wang X; Zhu J; Liu X
Avian Dis; 2011 Sep; 55(3):391-7. PubMed ID: 22017036
[TBL] [Abstract][Full Text] [Related]
6. Effect of fusion protein cleavage site sequence on generation of a genotype VII Newcastle disease virus vaccine.
Manoharan VK; Varghese BP; Paldurai A; Samal SK
PLoS One; 2018; 13(5):e0197253. PubMed ID: 29758054
[TBL] [Abstract][Full Text] [Related]
7. Generation by reverse genetics of an effective attenuated Newcastle disease virus vaccine based on a prevalent highly virulent Chinese strain.
Liu MM; Cheng JL; Yu XH; Qin ZM; Tian FL; Zhang GZ
Biotechnol Lett; 2015 Jun; 37(6):1287-96. PubMed ID: 25724719
[TBL] [Abstract][Full Text] [Related]
8. A novel recombinant attenuated Newcastle disease virus expressing H9 subtype hemagglutinin protected chickens from challenge by genotype VII virulent Newcastle disease virus and H9N2 avian influenza virus.
Xu X; Xue C; Liu X; Li J; Fei Y; Liu Z; Mu J; Bi Y; Qian J; Yin R; Ding Z
Vet Microbiol; 2019 Jan; 228():173-180. PubMed ID: 30593364
[TBL] [Abstract][Full Text] [Related]
9. Can genotype mismatch really affect the level of protection conferred by Newcastle disease vaccines against heterologous virulent strains?
Liu H; de Almeida RS; Gil P; Majó N; Nofrarías M; Briand FX; Jestin V; Albina E
Vaccine; 2018 Jun; 36(27):3917-3925. PubMed ID: 29843999
[TBL] [Abstract][Full Text] [Related]
10. Effect of phylogenetic diversity of velogenic Newcastle disease virus challenge on virus shedding post homologous and heterologous DNA vaccination in chickens.
Mohamed MH; Abdelaziz AM; Kumar S; Al-Habib MA; Megahed MM
Avian Pathol; 2016; 45(2):228-34. PubMed ID: 26813237
[TBL] [Abstract][Full Text] [Related]
11. Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge.
Miller PJ; King DJ; Afonso CL; Suarez DL
Vaccine; 2007 Oct; 25(41):7238-46. PubMed ID: 17719150
[TBL] [Abstract][Full Text] [Related]
12. Generation and evaluation of a recombinant Newcastle disease virus strain R2B with an altered fusion protein cleavage site as a vaccine candidate.
Yadav K; Pathak DC; Saikia DP; Debnath A; Ramakrishnan S; Dey S; Chellappa MM
Microb Pathog; 2018 May; 118():230-237. PubMed ID: 29578068
[TBL] [Abstract][Full Text] [Related]
13. Comparison of protection and viral shedding following vaccination with Newcastle disease virus strains of different genotypes used in vaccine formulation.
Wajid A; Basharat A; Bibi T; Rehmani SF
Trop Anim Health Prod; 2018 Oct; 50(7):1645-1651. PubMed ID: 29728823
[TBL] [Abstract][Full Text] [Related]
14. Characterization of live LaSota vaccine strain-induced protection in chickens upon early challenge with a virulent Newcastle disease virus of heterologous genotype.
Cornax I; Miller PJ; Afonso CL
Avian Dis; 2012 Sep; 56(3):464-70. PubMed ID: 23050461
[TBL] [Abstract][Full Text] [Related]
15. Genotype-matched Newcastle disease virus vaccine confers improved protection against genotype XII challenge: The importance of cytoplasmic tails in viral replication and vaccine design.
Izquierdo-Lara R; Chumbe A; Calderón K; Fernández-Díaz M; Vakharia VN
PLoS One; 2019; 14(11):e0209539. PubMed ID: 31725727
[TBL] [Abstract][Full Text] [Related]
16. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak.
Kapczynski DR; King DJ
Vaccine; 2005 May; 23(26):3424-33. PubMed ID: 15837366
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of fusion protein cleavage site sequences of Newcastle disease virus in genotype matched vaccines.
Kim SH; Chen Z; Yoshida A; Paldurai A; Xiao S; Samal SK
PLoS One; 2017; 12(3):e0173965. PubMed ID: 28339499
[TBL] [Abstract][Full Text] [Related]
18. Advancement in vaccination against Newcastle disease: recombinant HVT NDV provides high clinical protection and reduces challenge virus shedding with the absence of vaccine reactions.
Palya V; Kiss I; Tatár-Kis T; Mató T; Felföldi B; Gardin Y
Avian Dis; 2012 Jun; 56(2):282-7. PubMed ID: 22856183
[TBL] [Abstract][Full Text] [Related]
19. Characterisation of genotype VII Newcastle disease virus (NDV) isolated from NDV vaccinated chickens, and the efficacy of LaSota and recombinant genotype VII vaccines against challenge with velogenic NDV.
Roohani K; Tan SW; Yeap SK; Ideris A; Bejo MH; Omar AR
J Vet Sci; 2015; 16(4):447-57. PubMed ID: 25643805
[TBL] [Abstract][Full Text] [Related]
20. Comparison of viral shedding following vaccination with inactivated and live Newcastle disease vaccines formulated with wild-type and recombinant viruses.
Miller PJ; Estevez C; Yu Q; Suarez DL; King DJ
Avian Dis; 2009 Mar; 53(1):39-49. PubMed ID: 19432002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
